Klinisk signifikante afvigelser i laboratorieværdier (grad III og IV) i denne gruppe var lav med øget total bilirubin, AST og ALT rapporteret hos henholdsvis 2, 4%, 1, 6% og < 1% af patienterne.
Clinically significant laboratory abnormalities (Grades III and IV) in this group was low with elevated total bilirubin, AST and ALT reported in 2.4%, 1.6% and < 1% of patients respectively.